Market Size of Antacids Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 3.70 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Antacids Market Analysis
The Global Antacids Market size is expected to grow from USD 6,810.11 million in 2023 to USD 8,194.33 million by 2028, registering a CAGR of 3.7% during the forecast period (2023-2028).
The COVID-19 pandemic significantly impacted the market due to declining production and a labor shortage. The prices were higher than normal. However, because of the rising demand for new antacids and other medications, the market witnessed a favorable impact. This significantly increased the revenue of the market under study. Additionally, it was shown that various gastrointestinal medications successfully enhanced the clinical results of COVID-19 patients who were hospitalized. For instance, as per an article published in the View Open Access Journal in May 2022, acidosis-related pH promoted SARS-CoV-2 infection and suggested the existence of a positive feedback loop in which SARS-CoV-2 infection-induced acidosis enhances SARS-CoV-2 infection. Therefore, antacid therapy for acidosis COVID-19 patients was necessary during the pandemic. As per the above source, calcium carbonate nanoparticles (CaCO3-NPs) were an effective antacid nano antidote than sodium bicarbonate. Hence, the use of these medications increased during the pandemic and fueled the overall market growth. The studied market is anticipated to maintain its stronghold and grow significantly during the forecast period.
Factors such as the growing geriatric population suffering from gastroesophageal reflux disease (GERD), poor lifestyle choices leading to higher incidences of acidity, and side effects of drugs like non-steroidal, anti-inflammatory drugs are predicted to contribute to the market's growth over the analysis period.
As per a report released in May 2021 by HHS's Administration on Aging (AoA), the number of geriatric populations is expected to rise to 94.7 million by 2060. As per various sources, with the aging of the population, GERD is more common, with a prevalence of 20% or higher in the outpatient setting. Hence, the rising geriatric population is expected to rise, and the demand for antacids to treat GERD. Therefore, the market studied is anticipated to expand and grow during the forecast period.
Furthermore, according to a research report published in the Cureus journal in November 2021, the prevalence of GERD was 20.6% in the eastern region of Saudi Arabia. Numerous sociodemographic and lifestyle factors were linked to the illness. Therefore, rising prevalence would boost antacid demand and support market expansion over the projected period.
However, the growing number of alternatives available in the market to antacids and the ignorance of people towards the symptoms of acidity are expected to have an adverse impact on the market growth.
Antacids Industry Segmentation
As per the report's scope, antacids are widely available medications for slowing heartburn, sore stomach, acid indigestion, and stomach upset. It helps protect the stomach, duodenum, and esophagus from the harsh acids released. They provide quick relief from heartburn, a major symptom of gastroesophageal reflux disease and indigestion. The Antacids Market is Segmented by Formulation Type (Tablet, Powder, and Others), Distribution Channel (Hospital Pharmacies, E-Commerce, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.
| By Formulation Type | |
| Tablet | |
| Powder | |
| Other Formulation Types |
| By Distribution Channel | |
| Hospital Pharmacies | |
| E-Commerce | |
| Other Distribution Channels |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Antacids Market Size Summary
The antacids market is poised for significant growth, driven by factors such as an increasing geriatric population and lifestyle changes leading to higher incidences of gastrointestinal disorders like gastroesophageal reflux disease (GERD). The market experienced a favorable impact during the COVID-19 pandemic, as antacids were used to manage acidosis in infected patients, thereby boosting demand. The prevalence of GERD, particularly among the elderly, is expected to rise, further fueling the demand for antacids. The market is also witnessing a trend towards self-medication, especially in North America, where lifestyle changes have led to a surge in gastrointestinal issues. This has increased the demand for over-the-counter digestive products, including antacids.
The competitive landscape of the antacids market is moderately intense, with major players like Johnson & Johnson, Haleon, Sanofi S.A., Bayer AG, and Sun Pharmaceuticals Ltd. actively participating. These companies are focusing on research and development to introduce new and effective products, as well as seeking regulatory approvals to enhance their market offerings. The availability of chewable tablets with various flavors is also contributing to the segment's growth, as they improve patient adherence and provide accurate dosage. Despite the presence of alternatives and some consumer ignorance towards acidity symptoms, the market is expected to expand, supported by strategic acquisitions, collaborations, and partnerships among key players.
Antacids Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Geriatric Population Suffering from Gastroesophageal Reflux Disease (GERD)
-
1.2.2 Poor Lifestyle Choices Leading to Higher Incidences of Acidity
-
1.2.3 Side Effects of Drugs like Non-Steroidal Anti-Inflammatory Drugs
-
-
1.3 Market Restraints
-
1.3.1 Ignorance of People towards Symptoms of Acidity
-
1.3.2 Growing Number of Alternatives in the Market for Antacids
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Buyers/Consumers
-
1.4.2 Bargaining Power of Suppliers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Formulation Type
-
2.1.1 Tablet
-
2.1.2 Powder
-
2.1.3 Other Formulation Types
-
-
2.2 By Distribution Channel
-
2.2.1 Hospital Pharmacies
-
2.2.2 E-Commerce
-
2.2.3 Other Distribution Channels
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Antacids Market Size FAQs
What is the current Global Antacids Market size?
The Global Antacids Market is projected to register a CAGR of 3.70% during the forecast period (2024-2029)
Who are the key players in Global Antacids Market?
Sun Pharmaceuticals Ltd, Sanofi S.A, Bayer AG, Johnson & Johnson and Haleon are the major companies operating in the Global Antacids Market.
